These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 32730753)
61. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer. Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378 [TBL] [Abstract][Full Text] [Related]
62. Hypoxic conditions differentially regulate TAZ and YAP in cancer cells. Yan L; Cai Q; Xu Y Arch Biochem Biophys; 2014 Nov; 562():31-6. PubMed ID: 25078107 [TBL] [Abstract][Full Text] [Related]
63. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases. Adler JJ; Johnson DE; Heller BL; Bringman LR; Ranahan WP; Conwell MD; Sun Y; Hudmon A; Wells CD Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17368-73. PubMed ID: 24101513 [TBL] [Abstract][Full Text] [Related]
64. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
65. STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling. Zheng L; Xiang C; Li X; Guo Q; Gao L; Ni H; Xia Y; Xi T J Hematol Oncol; 2018 May; 11(1):72. PubMed ID: 29848346 [TBL] [Abstract][Full Text] [Related]
66. Two faces of Hippo: activate or suppress the Hippo pathway in cancer. Cao J; Huang W Anticancer Drugs; 2017 Nov; 28(10):1079-1085. PubMed ID: 28926422 [TBL] [Abstract][Full Text] [Related]
67. [Regulation of differentiation of mesenchymal stem cells by the Hippo pathway effectors TAZ/YAP]. Men T; Piao SH; Teng CB Yi Chuan; 2013 Nov; 35(11):1283-90. PubMed ID: 24579311 [TBL] [Abstract][Full Text] [Related]
68. Hypoxia-inducible factor 2α (HIF-2α) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activity. Ma X; Zhang H; Xue X; Shah YM J Biol Chem; 2017 Oct; 292(41):17046-17056. PubMed ID: 28848049 [TBL] [Abstract][Full Text] [Related]
69. S100A7 induction is repressed by YAP via the Hippo pathway in A431 cells. Li Y; Kong F; Wang J; Hu E; Wang R; Liu J; Xiao Q; Zhang W; He D; Xiao X Oncotarget; 2016 Jun; 7(25):38133-38142. PubMed ID: 27203549 [TBL] [Abstract][Full Text] [Related]
70. Tales from the Cryptkeeper: New Roles for Lats1/2 in Wnt-driven Homeostasis. Fu V; Guan KL Cell Stem Cell; 2020 May; 26(5):612-614. PubMed ID: 32386550 [TBL] [Abstract][Full Text] [Related]
71. YAP/TAZ for cancer therapy: opportunities and challenges (review). Guo L; Teng L Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178 [TBL] [Abstract][Full Text] [Related]
72. YAP/TAZ-CDC42 signaling regulates vascular tip cell migration. Sakabe M; Fan J; Odaka Y; Liu N; Hassan A; Duan X; Stump P; Byerly L; Donaldson M; Hao J; Fruttiger M; Lu QR; Zheng Y; Lang RA; Xin M Proc Natl Acad Sci U S A; 2017 Oct; 114(41):10918-10923. PubMed ID: 28973878 [TBL] [Abstract][Full Text] [Related]
73. Hippo Signaling Mediators Yap and Taz Are Required in the Epicardium for Coronary Vasculature Development. Singh A; Ramesh S; Cibi DM; Yun LS; Li J; Li L; Manderfield LJ; Olson EN; Epstein JA; Singh MK Cell Rep; 2016 May; 15(7):1384-1393. PubMed ID: 27160901 [TBL] [Abstract][Full Text] [Related]
74. The signaling protein Wnt5a promotes TGFβ1-mediated macrophage polarization and kidney fibrosis by inducing the transcriptional regulators Yap/Taz. Feng Y; Liang Y; Zhu X; Wang M; Gui Y; Lu Q; Gu M; Xue X; Sun X; He W; Yang J; Johnson RL; Dai C J Biol Chem; 2018 Dec; 293(50):19290-19302. PubMed ID: 30333225 [TBL] [Abstract][Full Text] [Related]
75. Prostaglandin E Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128 [TBL] [Abstract][Full Text] [Related]
76. Netrin-1 exerts oncogenic activities through enhancing Yes-associated protein stability. Qi Q; Li DY; Luo HR; Guan KL; Ye K Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7255-60. PubMed ID: 26039999 [TBL] [Abstract][Full Text] [Related]
77. SETD7 Controls Intestinal Regeneration and Tumorigenesis by Regulating Wnt/β-Catenin and Hippo/YAP Signaling. Oudhoff MJ; Braam MJS; Freeman SA; Wong D; Rattray DG; Wang J; Antignano F; Snyder K; Refaeli I; Hughes MR; McNagny KM; Gold MR; Arrowsmith CH; Sato T; Rossi FMV; Tatlock JH; Owen DR; Brown PJ; Zaph C Dev Cell; 2016 Apr; 37(1):47-57. PubMed ID: 27046831 [TBL] [Abstract][Full Text] [Related]
78. Cell type-dependent function of LATS1/2 in cancer cell growth. Pan WW; Moroishi T; Koo JH; Guan KL Oncogene; 2019 Apr; 38(14):2595-2610. PubMed ID: 30531839 [TBL] [Abstract][Full Text] [Related]
79. Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states. Sulaiman A; McGarry S; Li L; Jia D; Ooi S; Addison C; Dimitroulakos J; Arnaout A; Nessim C; Yao Z; Ji G; Song H; Gadde S; Li X; Wang L Mol Oncol; 2018 Apr; 12(4):423-440. PubMed ID: 29316250 [TBL] [Abstract][Full Text] [Related]
80. Insights into the Regulation of Yap/Taz from Cellular Systems and Mouse Models. Du W; Du W; Wan M; Zhou X; Xu X; Zheng L Curr Stem Cell Res Ther; 2018; 13(1):16-25. PubMed ID: 28042766 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]